Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.
Beverly MoyAntonio C WolffR Bryan RumbleKimberly H AllisonLisa Anne CareyPublished in: JCO oncology practice (2023)
5 med onc and path leaders help clinicians with HER2-low ADC decisions re patients, sequence, and AE.
Keyphrases
- epidermal growth factor receptor
- metastatic breast cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- endothelial cells
- advanced non small cell lung cancer
- chronic kidney disease
- squamous cell carcinoma
- magnetic resonance imaging
- computed tomography
- patient reported outcomes
- rectal cancer
- radiation therapy